English 
搜索
Hebei Lansheng Biotech Co., Ltd. ShangHai Yuelian Biotech Co., Ltd.

Rainbow accelerates investment in Annex II defending and Annex III in EUqrcode

Oct. 23, 2019

Favorites Print
Forward
Oct. 23, 2019

Rainbow accelerates investment in Annex II defending and Annex III in EU

As regarding the development of EU market as Rainbow’s strategic plan, the company is now making effort to increase the investment in EU continuously. Recently Rainbow announced they decided to invest about 50 million Euros in the next five years, to screen for important active ingredients and to invest in Annex II Defending & Annex III for marketable formulations in EU market. 
 
At the same time, Rainbow does not rule out the acquisition of EU localization companies in order to speed up the access to EU.
 
Since 2016, Rainbow has been investing in pesticide technical equivalences in the European Union. It has now obtained the equivalent identification of about 30 active ingredients in EU, and more than 50 active ingredients are in progress. This is a major step of building Rainbow’s One Stop Technical Material Supply Platform for EU market.  
 
Rainbow expects to lay a solid foundation for its continued growth during the period of 2025-2030 through continuous investment in EU market.
 
Source: AgroNews

0/1200

More from AgroNewsChange

Hot Topic More

I wanna post a press Comment

Subscribe 

Subscribe Email: *
Name:
Mobile Number:  

Comment  

0/1200

 

NEWSLETTER

Subscribe China Special Biweekly to send news related to your mailbox